IO Biotech Inc (NASDAQ:IOBT) price on Thursday, July 03, remained unchanged to $1.49.
A look at the stock’s price movement, the close in the last trading session was $1.49, moving within a range at $1.46 and $1.52. The beta value (5-Year monthly) was 0.367. Turning to its 52-week performance, $1.73 and $0.66 were the 52-week high and 52-week low respectively. Overall, IOBT moved -1.32% over the past month.
IO Biotech Inc’s market cap currently stands at around $98.16 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-14.
Turning to the stock’s technical picture we see that short term indicators suggest on average that IOBT is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend IOBT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
IOBT’s current price about 4.23% and 20.88% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 59.40, while 7-day volatility ratio is 7.73% and 8.28% in the 30-day chart. Further, IO Biotech Inc (IOBT) has a beta value of 0.36.
If we refocus on IO Biotech Inc (NASDAQ:IOBT), historical trading data shows that trading volumes averaged 0.14 over the past 10 days and 152.83K over the past 3 months. The company’s latest data on shares outstanding shows there are 65.88 million shares.
The 26.49% of IO Biotech Inc’s shares are in the hands of company insiders while institutional holders own 21.55% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.14 million on 2025-06-13, giving us a short ratio of 0.66. The data shows that as of 2025-06-13 short interest in IO Biotech Inc (IOBT) stood at 44.0 of shares outstanding, with shares short falling to 0.17 million registered in 2025-05-15. Current price change has pushed the stock 33.04% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IOBT stock continues to rise going into the next quarter.
